MaxCyte to Provide Updates on First-in-class CARMA™ Platform at BIO Investor Forum

October 15, 2019
Read Full Release

MaxCyte Presents Updates on First-in-class CARMA™ Platform at Upcoming Meetings

September 30, 2019
Read Full Release

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform

July 23, 2019
Read Full Release

MaxCyte Progresses Phase I Clinical Trial of Lead mRNA-based Cell Therapy from its CARMA™ Platform

May 8, 2019
Read Full Release

MaxCyte Presents at 22nd Annual ASGCT Meeting on Manufacturing Process for First CARMA™ Drug Candidate, Including One-Day Cell Processing

May 1, 2019
Read Full Release

MaxCyte to Present on CARMA™ Platform at Two Upcoming Industry Conferences in Europe

March 18, 2019
Read Full Release

MaxCyte to Present on Its CARMA™ Platform During Biotech Showcase™and Phacilitate: Leaders World/World Stem Cell Summit 2019

December 19, 2018
Read Full Release

MaxCyte to Present on CARMA™ Platform at BIO-EUROPE®

October 30, 2018
Read Full Release

MaxCyte Commences Dosing in First Clinical Trial in Solid Tumors

October 10, 2018
Read Full Release

MaxCyte, Inc. to Present on CARMA™ Platform at Two Upcoming Industry Conferences

August 29, 2018
Read Full Release

MaxCyte Receives US FDA Investigational New Drug Clearance for First Clinical Program

16 July 2018
Read Full Release

MaxCyte, Inc. to Present at 2018 BIO International Convention

May 29, 2018
Read Full Release

MaxCyte Appoints Dr.Claudio Dansky Ullmann as Chief Medical Officer

April 25, 2018
Read Full Release

MaxCyte, Inc. to Present at BIO Europe and BIOCapital USA Conferences this Month

March 12, 2018
Read Full Release

MaxCyte to Present Pre-Clinical CARMA Data at AACR Meeting

March 2, 2017
Read Full Release

MaxCyte Announces Strategic Immuno-Oncology Collaboration to Advance New Generation of CAR-based Cell Therapies

December 21, 2016
Read Full Release

MaxCyte Appoints Executive Vice President, Business and Strategic Development

November 2, 2016
Read Full Release

MaxCyte and The Johns Hopkins Kimmel Cancer Center Announce Strategic Immuno-Oncology Collaboration to Advance CAR T-cell Therapies

April 21, 2015
Read Full Release